| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 717 | 2021 |
| The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs RL Bromley, GE Mawer, M Briggs, C Cheyne, J Clayton-Smith, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (6), 637-643, 2013 | 412 | 2013 |
| IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study GA Baker, RL Bromley, M Briggs, CP Cheyne, MJ Cohen, ... Neurology 84 (4), 382-390, 2015 | 308 | 2015 |
| High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery FJ Rowe, LR Hepworth, C Howard, KL Hanna, CP Cheyne, J Currie PloS one 14 (3), e0213035, 2019 | 128 | 2019 |
| Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate RL Bromley, R Calderbank, CP Cheyne, C Rooney, P Trayner, ... Neurology 87 (18), 1943-1953, 2016 | 126 | 2016 |
| In utero exposure to levetiracetam vs valproate: development and language at 3 years of age R Shallcross, RL Bromley, CP Cheyne, M García-Fiñana, B Irwin, ... Neurology 82 (3), 213-221, 2014 | 109 | 2014 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 95 | 2021 |
| Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study M García-Fiñana, DM Hughes, CP Cheyne, G Burnside, M Stockbridge, ... bmj 374, 2021 | 80 | 2021 |
| Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK … MA Green, M García-Fiñana, B Barr, G Burnside, CP Cheyne, D Hughes, ... The Lancet Regional Health–Europe 6, 2021 | 77 | 2021 |
| Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine A Eleuteri, AC Fisher, DM Broadbent, M García-Fiñana, CP Cheyne, ... Diabetologia 60, 2174-2182, 2017 | 42 | 2017 |
| Metformin, a potential role in age-related macular degeneration: a systematic review and meta-analysis DF Romdhoniyyah, SP Harding, CP Cheyne, NAV Beare Ophthalmology and Therapy 10, 245-260, 2021 | 29 | 2021 |
| Delivery of a personalized treatment approach to women with epilepsy PE Voinescu, PB Pennell Seminars in neurology 37 (06), 611-623, 2017 | 28 | 2017 |
| Liverpool and Manchester Neurodevelopment Group. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs RL Bromley, GE Mawer, M Briggs, C Cheyne, J Clayton-Smith, ... J Neurol Neurosurg Psychiatry 84 (6), 637-643, 2013 | 28 | 2013 |
| Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk … DM Broadbent, CJ Sampson, A Wang, L Howard, AE Williams, SU Howlin, ... BMJ open 9 (6), e025788, 2019 | 24 | 2019 |
| Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules M García‐Fiñana, DM Hughes, CP Cheyne, DM Broadbent, A Wang, ... Diabetes, Obesity and Metabolism 21 (3), 560-568, 2019 | 23 | 2019 |
| Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT DM Broadbent, A Wang, CP Cheyne, M James, J Lathe, IM Stratton, ... Diabetologia 64 (1), 56-69, 2021 | 22 | 2021 |
| Detection of visual field loss in pituitary disease: peripheral kinetic versus central static FJ Rowe, CP Cheyne, M García-Fiñana, CP Noonan, C Howard, J Smith, ... Neuro-Ophthalmology 39 (3), 116-124, 2015 | 22 | 2015 |
| The effect of handedness on academic ability: a multivariate linear mixed model approach CP Cheyne, N Roberts, TJ Crow, SJ Leask, M García-Fiñana Laterality 15 (4), 451-464, 2010 | 18 | 2010 |
| Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis CJ Sampson, JC Tosh, CP Cheyne, D Broadbent, M James Systematic reviews 4, 1-6, 2015 | 14 | 2015 |
| Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B. 1.617 … K Pattni, D Hungerford, S Adams, I Buchan, CP Cheyne, M García-Fiñana, ... BMC infectious diseases 22 (1), 270, 2022 | 9 | 2022 |
